OBJECTIVES: Numerous studies indicate that certain genetic polymorphisms modify lead toxicokinetics. Metallothioneins are protective against the toxicity of many metals, including lead. The aim of this study was to determine whether the maternal metallothionein 2A (MT2A) -5 A/G single-nucleotide polymorphism is related to the lead levels in maternal blood, placental tissue and cord blood in 91 pregnant women and their newborns. METHODS: Venous blood from the mother was collected to investigate lead levels and MT2A polymorphism. Cord blood and placenta were collected for lead levels. Analyses were made using an Atomic Absorption Graphite Furnace Spectrophotometer. Standard PCR-RFLP technique was used to determine MT2A polymorphism. RESULTS: Blood lead levels of heterozygote genotype (AG) mothers were statistically higher than those of homozygote genotype (AA) (P < 0.05). Maternal lead levels were significantly associated with cord blood lead levels for pregnant women with AA genotype (P < 0.001). This association was not statistically significant for pregnant women with AG. In contrast, the mean value of cord blood lead level for newborns with mothers of AG genotype was slightly higher than others, though the difference was not significant. No significant difference existed in placenta lead levels between the groups. CONCLUSION: This study suggests that pregnant women with AG genotype for MT2A polymorphism might have high blood lead levels and their newborns may be at risk of low-level cord blood lead variation.
OBJECTIVES: Numerous studies indicate that certain genetic polymorphisms modify lead toxicokinetics. Metallothioneins are protective against the toxicity of many metals, including lead. The aim of this study was to determine whether the maternal metallothionein 2A (MT2A) -5 A/G single-nucleotide polymorphism is related to the lead levels in maternal blood, placental tissue and cord blood in 91 pregnant women and their newborns. METHODS: Venous blood from the mother was collected to investigate lead levels and MT2A polymorphism. Cord blood and placenta were collected for lead levels. Analyses were made using an Atomic Absorption Graphite Furnace Spectrophotometer. Standard PCR-RFLP technique was used to determine MT2A polymorphism. RESULTS: Blood lead levels of heterozygote genotype (AG) mothers were statistically higher than those of homozygote genotype (AA) (P < 0.05). Maternal lead levels were significantly associated with cord blood lead levels for pregnant women with AA genotype (P < 0.001). This association was not statistically significant for pregnant women with AG. In contrast, the mean value of cord blood lead level for newborns with mothers of AG genotype was slightly higher than others, though the difference was not significant. No significant difference existed in placenta lead levels between the groups. CONCLUSION: This study suggests that pregnant women with AG genotype for MT2A polymorphism might have high blood lead levels and their newborns may be at risk of low-level cord blood lead variation.
Authors: Wei Qu; Bhalchandra A Diwan; Jie Liu; Robert A Goyer; Tammy Dawson; John L Horton; M George Cherian; Michael P Waalkes Journal: Am J Pathol Date: 2002-03 Impact factor: 4.307
Authors: Richard Kia; Rowena L C Sison; James Heslop; Neil R Kitteringham; Neil Hanley; John S Mills; B Kevin Park; Chris E P Goldring Journal: Br J Clin Pharmacol Date: 2013-04 Impact factor: 4.335
Authors: Shanshan Zhou; Tatiana V Morozova; Yasmeen N Hussain; Sarah E Luoma; Lenovia McCoy; Akihiko Yamamoto; Trudy F C Mackay; Robert R H Anholt Journal: Environ Health Perspect Date: 2016-02-09 Impact factor: 9.031
Authors: Katarzyna Starska; Magdalena Bryś; Ewa Forma; Jurek Olszewski; Piotr Pietkiewicz; Iwona Lewy-Trenda; Olga Stasikowska-Kanicka; Marian Danilewicz; Anna Krześlak Journal: Tumour Biol Date: 2015-06-03
Authors: Shanshan Zhou; Sarah E Luoma; Genevieve E St Armour; Esha Thakkar; Trudy F C Mackay; Robert R H Anholt Journal: PLoS Genet Date: 2017-07-21 Impact factor: 5.917
Authors: Hsin-Liang Liu; Hung-Yi Chuang; Chien-Ning Hsu; Su-Shin Lee; Chen-Cheng Yang; Kuan-Ting Liu Journal: Int J Environ Res Public Health Date: 2020-04-23 Impact factor: 3.390